Literature DB >> 13559934

Prednisone in rheumatoid arthritis: metabolic and clinical effects.

L E WARD, H F POLLEY, M H POWER, H L MASON, C H SLOCUMB, P S HENCH.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; CORTISONE/therapeutic use; HYDROCORTISONE/therapeutic use; PREDNISONE/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13559934      PMCID： PMC1007029          DOI： 10.1136/ard.17.2.145

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Prednisone in the treatment of rheumatoid arthritis.

Authors:  A COHEN; R TURNER; R DUNSMORE
Journal:  N Engl J Med       Date:  1955-12-29       Impact factor: 91.245

2.  Prednisone and prednisolone as therapeutic agents; progress report on their integration into general medical practice.

Authors:  T D SPIES; R E STONE; G GARCIA LOPEZ; C M DIAZ TELLECHEA; R LOPEZ TOCA; A REBOREDO; R M SUAREZ
Journal:  J Am Med Assoc       Date:  1955-10-15

3.  Prednisone and plasma lipids.

Authors:  C I WANG; E T BOSSAK; D ADLERSBERG
Journal:  J Clin Endocrinol Metab       Date:  1955-10       Impact factor: 5.958

4.  Highly potent adrenal cortical steroids: structure and biologic activity.

Authors:  G W THORN; A E RENOLD; W I MORSE; A GOLDFIEN; W J REDDY
Journal:  Ann Intern Med       Date:  1955-11       Impact factor: 25.391

5.  Recent advances in rheumatic diseases.

Authors:  E W BOLAND
Journal:  Calif Med       Date:  1955-02

6.  Metacortandracin and 9-alpha-fluoro hydrocortisone acetate in rheumatic diseases.

Authors:  L VILLA; C B BALLABIO; G SALA
Journal:  Ann Rheum Dis       Date:  1955-09       Impact factor: 19.103

7.  Metabolic effects of metacortandralone and metacortandracin.

Authors:  J J BUNIM; R L BLACK; A J BOLLET; M M PECHET
Journal:  Ann N Y Acad Sci       Date:  1955-05-27       Impact factor: 5.691

8.  Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties.

Authors:  J J BUNIM; M M PECHET; A J BOLLET
Journal:  J Am Med Assoc       Date:  1955-01-22

9.  Observations on the metabolic effects of vitamin D in Fanconi's syndrome.

Authors:  R M SALASSA; M H POWER; J A ULRICH; A B HAYLES
Journal:  Proc Staff Meet Mayo Clin       Date:  1954-04-21

10.  Preliminary clinical trials with prednisone (meticorten) in rheumatic diseases; comparative antirheumatic potency, metabolic activity, and hormonal properties.

Authors:  J R DORDICK; E J GLUCK
Journal:  J Am Med Assoc       Date:  1955-05-21
View more
  7 in total

Review 1.  Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer.

Authors:  Richard J Auchus; Margaret K Yu; Suzanne Nguyen; Suneel D Mundle
Journal:  Oncologist       Date:  2014-10-31

2.  Effect of certain anti-arthritic compounds on the permeability of synovial membrane in the rabbit.

Authors:  G W SHARP
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

3.  Axon reflex sweating in rheumatoid arthritis.

Authors:  J L KALLIOMAKI; H A SAARIMAA; P TOIVANEN
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

4.  Rheumatology practice at Mayo Clinic: the first 40 years-1920 to 1960.

Authors:  Gene G Hunder; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

5.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1959-02-14

6.  Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.

Authors:  Shuling Li; Doyt L Conn; Athan Tiliakos; Gaobin Bao; Kirk A Easley
Journal:  Clin Rheumatol       Date:  2018-01-03       Impact factor: 2.980

7.  Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis - the TryCort study.

Authors:  Uta Kiltz; Christine von Zabern; Xenofon Baraliakos; Frank Heldmann; Bernd Mintrop; Michael Sarholz; Dietmar Krause; Friedrich Dybowski; Ludwig Kalthoff; Jürgen Braun
Journal:  Arthritis Res Ther       Date:  2017-04-07       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.